Thomas Dayspring
@drlipid
MD, FACP, FNLA - Clinical Lipidologist: Tweets/Re-Tweets do not represent endorsements/medical advice
ID: 56916619
15-07-2009 03:50:32
19,19K Tweet
37,37K Followers
602 Following
Here is an incredible article about LDL-C exposure over time and so sad it is firewalled for $40. Anyone advising patients about apoB or LDL-C should get this from their hospital library. National Lipid Association European Atherosclerosis Society European Atherosclerosis Society European Society of Cardiology #cholesterol
Lipidaholics: Do not be ready to bury fenofibrate just yet pubmed.ncbi.nlm.nih.gov/39075919/ Also there are retinal benefits. National Lipid Association European Atherosclerosis Society European Society of Cardiology International Atherosclerosis Society (IAS) #fenofibrate
With respect to the authors, like so many guidelines these will have little use in the real world and will be ignored. I agree with Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 on the misclassification of risk categories. Likewise it is also absurd to still suggest using high dose statins which almost no clinicians
Lipidaholics. All interested in sane advice on nutrition and lipids should follow my longtime friend and the NLA’s nutritional guru Carol Kirkpatrick, PhD, MPH, RDN, CLS, FNLA
Today's #LipidXcellence comes to us from the Foundation of the NLA with their #TweetorialTuesday breaking down what your patients need to know about lipid testing and what resources are available to them! Share with your patients! #CholesterolMonth #LipidXcellence #KnowledgeIsPower
#FacultyForumFriday is here! Thomas Dayspring is with us to answer your questions throughout the day! Comment on this post with your question and tag Thomas Dayspring! #LipidXcellence